SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 28.10+5.6%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (3779)9/15/1997 11:09:00 PM
From: Cacaito   of 17367
 
300,000 sepsis in the USA a year ,the very bad ones (quick guess, no time to get real numbers) and BPI will be a $1000 dollars per treatment (not per dose)and again quick guess of an Intensive Care Unit type of drug (like surfactant in babies about $400 to $800 per treatment) considering that it will save lives, hospital time, and long term disabilities. This is $300,000,000 million in sales. When Lipo was testing a sepsis type of drug it was called a $1 billion drug. BPI is this type of drug if... Myself did not bet in Lipo, neither in ABTI I did not believe neither in the science, nor in their type II studies. But here I do have my money in, and I am ready to go triple more if the meningo trial comes positive. Heavy accumulation is clear by many indicators: BOP,TSV,OBV,CMS, and the obvious up in prices with persistent heavy volume. Ride the tide.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext